The n-butanolic fraction of a methanolic extract (80%) from aerial parts of Ajuga chamaecistus ssp. tomentella was analysed using different chromatographic methods. Column (CC) and high-performance liquid chromatography (HPLC) were used for isolation and purifi cation. 13 C, 1 H NMR, H-H COSY, HSQC, HMBC, and ESI-MS were employed for identifi cation of the compounds isolated from this fraction. The structures of the compounds were determined to be cis-melilotoside (1), trans-melilotoside (2), lavandulifolioside (3), 20-hydroxyecdysone (4), leonoside B (5), martynoside (6), ajugalactone (7), makisterone A (8), and 24-dehydroprecyasterone (9). This is the fi rst report on the presence of cis-and transmelilotoside in Ajuga species. Cytotoxic evaluation of the n-butanolic fraction, cis-and transmelilotoside against cancer (T47D, HT-29, and Caco-2) and normal (NIH 3T3) cell lines by the mitochondrial tetrazolium test (MTT) showed no cytotoxic effects up to 400 µg/mL. The results of this study suggest that melilotoside, phenylethyl glycosides, and phytoecdysteroids are the main constituents of the n-butanolic fraction of Ajuga chamaecistus ssp. tomentella.
Introduction
More than one hundred species including fi fty varieties and subspecies of Ajuga (Lamiaceae) are distributed throughout the world. The genus Ajuga with the common name bugle is found in China, Korea, Japan, and throughout Europe. Five species of this annual and perennial genus are found in Iran, of which Ajuga chamaecistus contains several exclusive subspecies, including A. chamaecistus ssp. tomentella (Mozaffarian, 2007) . Some species belonging to this genus are used in traditional medicine of different countries of the world, including Iran, for treatment of joints pains, gout, and jaundice (Naghibi et al., 2005) . A broad range of biological effects has been reported from different species of Ajuga such as hypoglycemic (Hilaly and Lyoussi, 2002) , treatment of joint disease (Ono et al., 2008) , anti-infl ammatory (Gautam et al., 2011) , and antimalarial (Kuria et al., 2001) . Many phytochemical studies on Ajuga species were performed which led to the isolation of phytoecdysteroids (Vanyolos et al., 2009; Castro et al., 2008) , diterpenoids (Coll, 2002) , iridoids (Manguro et al., 2007) , and phenylethyl glycosides (Akbay et al., 2003) . The aim of the present study was a phytochemical investigation of the n-butanolic fraction obtained from aerial parts of Ajuga chamaecistus ssp. tomentella, collected in Tehran (Iran), which has not been previously reported. Furthermore, we examined the cytotoxicity of the n-butanolic fraction and two major constituents, isolated from this fraction, against cancer and normal cell lines (T47D, Caco-2, HT-29, and NIH 3T3) by the MTT assay. 
Major Constituents and Cytotoxic Effects of

Material and Methods
General experimental procedures
1 H and 13 C NMR spectroscopy of compounds 1 and 2 were performed in CD 3 OD on a Bruker Avance DPX 400 spectrometer (Karlsruhe, Germany) [400 MHz, tetramethylsilane (TMS) as internal standard].
1 H and 13 C NMR spectra of compounds 3 -9 were acquired in CD 3 OD on a Jeol ECX-400 spectrometer (Peabody, MA, USA) (400 MHz, TMS as internal standard).
1 H-1 H COSY, HMBC, and HSQC spectra were obtained on a Bruker DRX 500 MHz spectro meter. ESI-mass spectra were recorded on an Agilent 6210 ESI-TOP spectrometer (Santa Clara, CA, USA). Column chromatography (CC) was performed using Sephadex LH-20 (45 × 4.5 cm, lipophilic Sephadex, 25 -100 µm; Sigma, Dorset, UK) and RP-18 (30 × 4.5 cm, Lichroprep RP-18, 40 -63 µm; Merck, Darmstadt, Germany) columns. Analytical and preparative high-performance liquid chromatography (HPLC) separations were performed on a Shimadzu LC-10AD pumping system (Kyoto, Japan) with a Shimadzu variable wavelength detector (220 nm) equipped with a Knauer (Berlin, Germany) Eurospher 100 C-18 (7 µm, 250 × 4 mm) and Nucleosil 300-C18 (10 µm, 250 × 16 mm) column, respectively. 
Plant material
Extraction and isolation
The air-dried and ground plants of A. chamaecistus ssp. tomentella (1 kg) were extracted with 80% methanol (7 × 2.5 L) at room temperature and concentrated under reduced pressure to give a dark brown extract (180 g). The extract (150 g) was defatted through repeated extraction with nhexane. The defatted extract was partitioned successively between 80% methanol, diethyl ether, and n-butanol. Twenty g of the n-butanolic fraction were loaded on a Sephadex LH-20 (150 g) column and eluted with aqueous methanol (60%) to afford 4 fractions. Fraction 2 (10 g) was chromatographed on an RP-18 column, under medium pressure, and eluted with a gradient of water and methanol (80:20 -50:50 v/v) to afford 5 fractions (B-F). Fraction B (8 g) was rechromatographed on RP-18 material with a gradient of aqueous methanol (5%, 20%, and 50%) to give 3 fractions (B 1 -B 3 ). B 1 (200 mg) was subjected to se mipreparative reversed phase (RP)-HPLC using gradient elution with aqueous methanol (10% -35%; fl ow-rate, 1 mL/min; time per run, 30 min) to afford compound 1 (14 mg). Compound 2 (20 mg) was obtained by preparative RP-HPLC and a gradient of aqueous methanol (30% -35%) within 40 min from fraction B 2 (190 mg). Fraction B 3 (2.5 g) was chromatographed on an RP-18 column eluted with a gradient of water/methanol (80:20 -50:50 v/v) to give 9 fractions (B 3.1 -B 3.9 ). Purifi cation of B 3.2 (200 mg) using preparative RP-HPLC with a gradient of aqueous methanol (30% -60%; fl ow-rate, 7 mL/min) within 60 min afforded compound 3 (5 mg) and compound 4 (80 mg). Fraction B 3.7 (144 mg) was subjected to RP-HPLC with aqueous methanol (35% -60%) to give compounds 5 (13.5 mg) and 6 (17.6 mg) within 60 min. Fraction C (200 mg) was purifi ed by RP-HPLC with a gradient of aqueous methanol (30% -60%) within 60 min to obtain compound 7 (8 mg) and compound 6 (11.5 mg). Fraction C (100 mg) was further purifi ed by RP-HPLC using a gradient of water/acetonitrile (80:20 -65:35) to afford compound 8 (1 mg) and compound 9 (1 mg). Direct sunlight was excluded during extraction and purifi cation of the compounds.
cis-Melilotoside ( .24 Hz, Glu-H-1'), 3.87 (1H, Ha-6'), 3.68 (1H, Hb-6'), 3.47 (1H, H-3'), 3.45 (1H, H-2'), 3.40 (2H, H-4', H-5'). 
Cell culture
The colon carcinoma (HT-29), colorectal adenocarcinoma (Caco-2), and breast ductal carcinoma (T47D) cell lines, respectively, were maintained as exponentially growing cultures in RPMI 1640 cell culture medium (PAA, Pasching, Austria) supplemented with 10% fetal bovine serum (FBS; PAA) for HT-29 cells and 15% FBS for Caco-2 and T47D cells. The Swiss mouse embryo fi broblast (NIH 3T3) cell line was kept in Dulbecco's modifi ed Eagle's medium (DMEM; PAA) supplemented with 10% FBS. One hundred IU/mL penicillin and 100 µg/mL streptomycin (Roche, Penzberg, Germany) were added to the media. All cell lines were cultured at 37 C in air/CO 2 (95:5 v/v) atmosphere.
Determination of cell viability by the MTT assay
Cytotoxic activities of the n-butanolic fraction, cis-and trans-melilotoside from Ajuga chamaecistus ssp. tomentella against breast ductal carcinoma (T47D), colon carcinoma (HT-29), colorectal adenocarcinoma (Caco-2), and Swiss mouse embryo fi broblast (NIH 3T3) cell lines were performed according to our previous study (Khanavi et al., 2010) by the mitochondrial tetrazolium test (MTT).
Results and Discussion
Isolated compounds 1 -9 from the n-butanolic fraction of the total methanolic extract of aerial parts of Ajuga chamaecistus ssp. tomentella were identifi ed by comparison of their NMR ( 1 H, 13 C NMR, HMBC, HSQC and 1 H-1 H COSY) and ESI-mass spectral data with those reported in the literature.
Compounds 1 and 2 (Fig. 1) were identifi ed as cis-melilotoside and trans-melilotoside, respectively. This is the fi rst report on the occurrence of cis-and trans-melilotosides in the genus Ajuga. Melilotoside is a coumaric acid derivative which was reported for the fi rst time from Melilotus altissima and M. arvensis (Takaishi, 1968) . cis-Melilotoside has been reported from several plants (Ferreira and Rodriguezde Oliveira, 2010; Yang et al., 2007a, b) , also there is an older report on the occurrence of both cis-and transforms of melilotoside in Melilotus albus depending on growing conditions (Kahnt, 1962) . Antiprotozoal activity of melilotoside isolated from Teloxys graveolens, a medicinal plant for treatment of dysentery and diarrhea, has been shown (Calzada et al., 2003) .
Compounds 3, 5, and 6 ( Fig. 1) were characterized as phenylethanoid glycosides, lavandulifolioside (3), leonoside B (5), and martynoside (6), by comparison of their spectral data with literature values (Basaran et al., 1988; Calis et al., 1992; Sasaki et al., 1978) . This group of phenolic compounds has interesting biological properties such as antimicrobial, antibacterial, cytotoxic, antioxidant, enzyme inhibitory, and immunomodulatory. Lavandulifolioside, a trisaccharide phenylethyl glycoside, showed inhibition of peroxylipid formation (Jimenez and Riguera, 1994) , a negative chronotropic effect, and decrease of blood pressure (Milkowska-Leyck et al., 2002) . Several pharmacological activities of martynoside have been reported, including antioxidant (Miao et al., 2003) and estrogenic/antiestrogenic properties in breast cancer cells (Papoutsi et al., 2006) .
The isolated compounds 4 and 7 -9 ( Fig. 1 ) were identifi ed as ecdysteroids, 20-hydroxyecdysone (4), ajugalactone (7), makisterone A (8), and 24-dehydroprecyasterone (9) by comparison of their spectral data with data in the literature (Wessner et al., 1992; Imai et al., 1968 Imai et al., , 1970 . The ecdysteroids are a large class of polyhydroxysteroids isolated from both the animal and plant kingdom. Most of the Ajuga species have been used in traditional medicine all over the world. Several studies have shown that ecdysteroids isolated from Ajuga species are responsible for their biological activities. This group of natural products produces a wide range of pharmacological activities in mammals, including adaptogenic and anabolic, and shows increasing protein synthesis in muscles (Gorelick-Feldman et al., 2010) , antidiabetic and hypoglycemic (Hamden et al., 2008; Kutepova et al., 2001) , hepatoprotective, immunoprotective, wound-healing (Dinan, 2009) , antioxidant, and free radical scavenging effects (Cai et al., 2002) , and perhaps even antitumour effects (Akbay et al., 2002) . 20-Hydroxyecdysone and cyasterone, in addition to ajugalactone, seem to be the most common compounds in Ajuga species (Ramazanov, 2005) .
In the cytotoxic evaluation of the n-butanolic fraction, cis-(1) and trans-melilotosides (2) did not show cytotoxic effects up to 400 µg/mL against cancer (T47D, HT-29, and Caco-2) and normal (NIH 3T3) cell lines in the MTT assay.
Previous to this study, we isolated three major compounds (20-hydroxyecdysone, cyasterone, and 8-acetylharpagide) from the diethyl ether fraction of Ajuga chamaecistus ssp. tomentella, which were inactive in the cytotoxicity evaluation (Sadati et al., 2012) In conclusion, our study showed that cis-and trans-melilotosides, phenylethyl glycosides, and phytoecdysteroids can be considered major constituents of the n-butanolic fraction of Ajuga chamaecistus ssp. tomentella. According to these results, it can be stated that the n-butanolic fraction and two major compounds isolated from this fraction are not cytotoxic against cancer and normal cell lines.
